What Researchers Did
This study investigated the relationship between the timing of hyperbaric oxygen therapy (HBOT) after carbon monoxide exposure and the development of delayed neurological problems in 167 patients.
What They Found
Researchers found that patients with a Glasgow Coma Scale (GCS) score of 9 or less had a 5.059 times higher chance of developing delayed neurological sequelae (DNS). Crucially, patients who received HBOT 200 minutes or more after carbon monoxide exposure had an 18.971 times higher chance of developing DNS, suggesting that quicker treatment may be beneficial.
Canadian Relevance
Carbon monoxide poisoning is a Health Canada-recognised indication for hyperbaric oxygen therapy. While this study was not conducted in Canada, its findings are relevant to Canadian healthcare practices for managing this condition.
Study Limitations
The study was conducted at a single hospital, which may limit how broadly its findings can be applied to other patient populations.